Business Description
Polyrizon Ltd
ISIN : IL0011814113
Description
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.98 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 70 | |||||
3-Year EPS without NRI Growth Rate | 65.7 | |||||
3-Year FCF Growth Rate | 74 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.97 | |||||
9-Day RSI | 51.41 | |||||
14-Day RSI | 48.82 | |||||
3-1 Month Momentum % | 22.2 | |||||
6-1 Month Momentum % | 81.51 | |||||
12-1 Month Momentum % | 254.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 29.03 | |||||
Quick Ratio | 29.03 | |||||
Cash Ratio | 28.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -712.3 | |||||
Shareholder Yield % | -75.94 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -22.41 | |||||
ROA % | -21.88 | |||||
ROIC % | -119.8 | |||||
3-Year ROIIC % | -68.16 | |||||
ROC (Joel Greenblatt) % | -54234.38 | |||||
ROCE % | -38.86 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.97 | |||||
Price-to-Tangible-Book | 1.1 | |||||
EV-to-EBIT | -4.67 | |||||
EV-to-EBITDA | -4.96 | |||||
EV-to-FCF | -5.96 | |||||
| Price-to-Net-Current-Asset-Value | 1.63 | |||||
| Price-to-Net-Cash | 1.69 | |||||
Earnings Yield (Greenblatt) % | -21.41 | |||||
FCF Yield % | -17.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PLRZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Polyrizon Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.684 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 191.71 | ||
| 14-Day RSI | 48.82 | ||
| 14-Day ATR ($) | 1.382875 | ||
| 20-Day SMA ($) | 12.1815 | ||
| 12-1 Month Momentum % | 254.74 | ||
| 52-Week Range ($) | 2.879999 - 18.2 | ||
| Shares Outstanding (Mil) | 2.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Polyrizon Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Polyrizon Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 151 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 60 days | ||
| General meeting for 2026 | 2026-07-13 15:00 | In 12 days | ||
| First quarter earnings results for 2026 | 2026-07-02 | 12.52 (-1.18%) | ||
| Annual report for 2025 | 2026-03-25 | 13.58 (-5.50%) | ||
| 0.166667:1 Stock Split | 2025-11-28 | 3.13 (-8.39%) | ||
| 0.004:1 Stock Split | 2025-05-27 | 5.10 (-15.00%) | ||
| General meeting for 2025 | 2025-04-17 16:00 | 544.50 (-0.82%) | ||
| Annual report for 2024 | 2025-03-11 | 1,200.00 (-1.23%) |
Show
Entries
Polyrizon Ltd Frequently Asked Questions
What is Polyrizon Ltd(PLRZ)'s stock price today?
The current price of PLRZ is $12.61. The 52 week high of PLRZ is $18.20 and 52 week low is $2.88.
When is next earnings date of Polyrizon Ltd(PLRZ)?
The next earnings date of Polyrizon Ltd(PLRZ) is 2026-07-02 Est..
Does Polyrizon Ltd(PLRZ) pay dividends? If so, how much?
Polyrizon Ltd(PLRZ) does not pay dividend.
Guru Commentaries on NAS:PLRZ
No articles.
Press Release
Articles on Polyrizon Ltd
No articles.
Headlines
See More- 1
Jun 17, 2026
Polyrizon receives U.S. patent publication notice for nasal drug delivery platform
Seeking Alpha • 7:53am
Jun 10, 2026
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers